Literature DB >> 16890814

HIV/AIDS harm reduction in Iran.

Emran Razzaghi1, Bijan Nassirimanesh, Parviz Afshar, Kelechi Ohiri, Mariam Claeson, Robert Power.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16890814     DOI： 10.1016/S0140-6736(06)69132-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  29 in total

1.  The evidence does not speak for itself: The role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US cities.

Authors:  Sean T Allen; Monica S Ruiz; Allison O'Rourke
Journal:  Int J Drug Policy       Date:  2015-04-15

2.  Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.

Authors:  Saman Zamani; Marziyeh Farnia; Alireza Torknejad; Behrouz Abbasi Alaei; Mehran Gholizadeh; Farzad Kasraee; Masako Ono-Kihara; Koji Oba; Masahiro Kihara
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

3.  Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.

Authors:  Abdul Nasir; Catherine S Todd; M Raza Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  Int J Drug Policy       Date:  2010-12-10

Review 4.  Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence.

Authors:  Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Behrang Shadloo; Alireza Noroozi; Mohsen Malekinejad
Journal:  Int J Drug Policy       Date:  2015-05-12

5.  Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.

Authors:  Ruyan Rahnama; Minoo Mohraz; Ali Mirzazadeh; George Rutherford; Willi McFarland; Gholamreza Akbari; Mohsen Malekinejad
Journal:  Int J Drug Policy       Date:  2014-06-02

6.  Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.

Authors:  Ghobad Moradi; Marzieh Farnia; Mostafa Shokoohi; Mohammad Shahbazi; Babak Moazen; Khaled Rahmani
Journal:  Int J Health Policy Manag       Date:  2015-03-12

Review 7.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

8.  Maintenance therapy with opium tincture for injecting drug users; implications for prevention from viral infections.

Authors:  Zahra Alam Mehrjerdi; Mehran Zarghami
Journal:  Hepat Mon       Date:  2013-04-16       Impact factor: 0.660

9.  Norjizak injection: a critical risk for transmitting blood-borne infectious diseases.

Authors:  Zahra Alam Mehrjerdi
Journal:  Hepat Mon       Date:  2013-04-06       Impact factor: 0.660

10.  An emerging trend of methamphetamine injection in iran: a critical target for research on blood-borne infection diseases.

Authors:  Zahra Alam Mehrjerdi; Alireza Noroozi
Journal:  Hepat Mon       Date:  2013-02-28       Impact factor: 0.660
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.